Related Experiment Video
Updated: Aug 9, 2026
09:53
Screening Assay for Oxidative Stress in a Feline Astrocyte Cell Line, G355-5
Published on: July 13, 2011
Homocysteine and neurologic disease
1Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9036. RdiazA@mednet.swmed.edu.
Archives of Neurology
|October 13, 2000
Summary
Elevated homocysteine levels are a significant risk factor for vascular and neurological diseases. Supplementation with folic acid, vitamin B6, and vitamin B12 may help normalize levels and reduce disease incidence.
Area of Science:
- Biochemistry and Metabolism
- Neurology and Vascular Medicine
Background:
- Homocysteine, a sulfur-containing amino acid, is central to thiol metabolism.
- Hyperhomocysteinemia is an emerging risk factor for vascular diseases like stroke, independent of traditional factors.
- Homocysteine may be linked to neurodegenerative disorders and is affected by anticonvulsant medications.
Purpose of the Study:
- To explore the significance of homocysteine in vascular and neurological diseases.
- To investigate the potential of polyvitamin therapy in managing hyperhomocysteinemia.
Main Methods:
- Review of existing literature on homocysteine metabolism and its clinical implications.
- Analysis of the relationship between homocysteine levels, vascular disease risk, and neurological conditions.
- Evaluation of the efficacy of folic acid, vitamin B6, and vitamin B12 supplementation.
Main Results:
- Hyperhomocysteinemia is a recognized risk factor for stroke and other vascular conditions.
- Elevated homocysteine levels can be reduced through dietary supplementation with specific B vitamins.
- Anticonvulsant drugs can increase homocysteine levels, potentially explaining their teratogenic effects.
Conclusions:
- Polyvitamin therapy (folic acid, vitamin B6, vitamin B12) offers a promising, inexpensive approach to lower homocysteine.
- Managing homocysteine levels is crucial for preventing vascular disease and understanding neurological drug effects.
- Increased clinical knowledge of homocysteine metabolism and its management is vital for neurological patient care.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...